Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.34
-0.1100-2.02%
Pre-market: 5.21-0.1300-2.43%05:49 EDT
Volume:891.38K
Turnover:4.71M
Market Cap:290.16M
PE:-1.48
High:5.44
Open:5.24
Low:5.12
Close:5.45
Loading ...

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

GlobeNewswire
·
20 Mar

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers With Five Critical Medical Countermeasure Products

THOMSON REUTERS
·
18 Mar

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

GlobeNewswire
·
18 Mar

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

GlobeNewswire
·
13 Mar

INDIA STOCKS-Indian stocks set to open lower, tracking global market sell-off

Reuters
·
11 Mar

Emergent BioSolutions Sells Baltimore Facility to Syngene

TIPRANKS
·
11 Mar

BUZZ-Emergent BioSolutions drops after Syngene buys co's unit for $36.5 mln

Reuters
·
11 Mar

CORRECTED-India's Syngene International acquires first US biologics facility for $36.5 mln

Reuters
·
10 Mar

Emergent to Sell Baltimore-Bayview Facility for $36.5 Million

MT Newswires Live
·
10 Mar

Emergent BioSolutions Inc - to Sell Baltimore-Bayview Facility for $36.5 Million

THOMSON REUTERS
·
10 Mar

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

THOMSON REUTERS
·
10 Mar

Press Release: Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Dow Jones
·
10 Mar

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Zacks
·
06 Mar

Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
06 Mar

Is Emergent BioSolutions (NYSE:EBS) Weighed On By Its Debt Load?

Simply Wall St.
·
06 Mar

Emergent BioSolutions’ Earnings Call: Balancing Achievements and Challenges

TIPRANKS
·
05 Mar

Emergent BioSolutions falls -16.0%

TIPRANKS
·
04 Mar

Emergent BioSolutions Shares Down 14.2% After Quarterly Revenue Falls

THOMSON REUTERS
·
04 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Wellgistics, Capricor, Wave Life Sciences

Reuters
·
04 Mar

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar